Search research articles
Contact Us
Filters
Showing results (61-70 of 118) with videos related to
Page
of 12
Sort By:
Bone Marrow Transplantation
|
May 26, 2018
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis
Tania Jain, Katie L Kunze, M'hamed Temkit, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 14, 2018
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study
Tania Jain, Heidi E Kosiorek, Shu T Kung, et al.
Leukemia & Lymphoma
|
April 5, 2022
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, et al.
Leukemia & Lymphoma
|
February 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation
John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur, et al.
Haematologica
|
June 11, 2026
Evolution to complex karyotype disease in mono-allelic <i>TP53</i>-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study
Priyanka Fernandes, Sergiu Pasca, Tania Jain, et al.
Leukemia & Lymphoma
|
February 6, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Khaled Sanber, Kevin Ye, Hua-Ling Tsai, et al.
Leukemia
|
October 19, 2021
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study
Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, et al.
Frontiers in Immunology
|
June 25, 2024
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma
Doris K Hansen, Binod Dhakal, Mehdi Hamadani, et al.
Leukemia Research
|
September 17, 2025
Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities
J Preston Claiborne, Daniel Li, Hua-Ling Tsai, et al.
Haematologica
|
December 15, 2022
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine
Theodoros Karantanos, Patric Teodorescu, Marios Arvanitis, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 118) with videos related to
Sort By:
Page
of 12
Bone Marrow Transplantation
|
May 26, 2018
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis
Tania Jain, Katie L Kunze, M'hamed Temkit, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 14, 2018
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study
Tania Jain, Heidi E Kosiorek, Shu T Kung, et al.
Leukemia & Lymphoma
|
April 5, 2022
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, et al.
Leukemia & Lymphoma
|
February 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation
John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur, et al.
Haematologica
|
June 11, 2026
Evolution to complex karyotype disease in mono-allelic <i>TP53</i>-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study
Priyanka Fernandes, Sergiu Pasca, Tania Jain, et al.
Leukemia & Lymphoma
|
February 6, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Khaled Sanber, Kevin Ye, Hua-Ling Tsai, et al.
Leukemia
|
October 19, 2021
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study
Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, et al.
Frontiers in Immunology
|
June 25, 2024
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma
Doris K Hansen, Binod Dhakal, Mehdi Hamadani, et al.
Leukemia Research
|
September 17, 2025
Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities
J Preston Claiborne, Daniel Li, Hua-Ling Tsai, et al.
Haematologica
|
December 15, 2022
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine
Theodoros Karantanos, Patric Teodorescu, Marios Arvanitis, et al.
Page
of 12